Prev: The Art of Interpreting Antinuclear Antibodies (ANAs) in Everyday PracticeNext: Understanding and interpreting antinuclear antibody tests in systemic rheumatic diseases

Record 047 · Review · 2022
The International Consensus on ANA Patterns (ICAP) in 2021—The 6th Workshop and Current Perspectives
Journal of Applied Laboratory Medicine · requested inclusion
“Consensus report from the 6th ICAP Workshop (Dresden, September 6, 2021) summarizing harmonization of HEp-2 indirect immunofluorescence pattern nomenclature and reporting, plus the committee's forward plans.”
Consensus report from the 6th ICAP Workshop (Dresden, September 6, 2021) summarizing harmonization of HEp-2 indirect immunofluorescence pattern nomenclature and reporting, plus the committee's forward plans. Candidate notes: ICAP harmonization covers nuclear, cytoplasmic and mitotic HEp-2 IFA patterns under a standardized AC-coded nomenclature for interpretation and reporting The 6th workshop addressed pattern classification updates (including AC-4 fine-speckled pattern variants) and committee plans Emphasis on fostering accurate reading, interpretation and reporting of HEp-2 IFA images by laboratories, clinicians and industry Limits noted in the record: Consensus statement/meeting report rather than an evidence-graded review Summarizes expert discussions; contains no new primary data A positive ANA is not a diagnosis. Claims in this record are not verified.
A positive ANA is not a diagnosis. Claims in this record are not verified.
source
- interpretation
- pattern
- testing-method
Review



